HCPCS H0020: Methadone Administration and Services
HCPCS Level II code H0020 represents methadone administration and associated services provided by licensed opioid treatment programs. This code captures the provision of methadone medication as part of medication-assisted treatment for opioid use disorder and is central to billing for clinic-based dispensing and supervised dosing. Nationally, methadone programs remain a key component of the continuum of care for opioid dependence, and accurate use of H0020 affects program revenue, compliance with payer requirements, and access to outpatient treatment.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical sites of service, and related service categories used alongside methadone administration. The publication summarizes common billing relationships, crosswalks to related behavioral health codes, and typical ICD-10 diagnostic contexts for which H0020 is billed. It also highlights operational considerations that influence claim acceptance and common companion services billed with methadone administration.
This summary is intended for a national audience of billing professionals, compliance officers, and clinical administrators seeking clarity on the clinical and billing scope of HCPCS Level II code H0020. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for hcpcs H0020 policy alerts
Get alerted when payer policies referencing H0020 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code H0020 covers alcohol and/or drug services: methadone administration and/or service where the program provides the methadone medication. The primary service type is medication-assisted treatment (methadone administration/services) for individuals with opioid use disorder. The typical site of service is an accredited outpatient opioid treatment program or licensed clinic that dispenses methadone as part of a structured treatment regimen.
National Reimbursement Benchmarks
National commercial rates for HCPCS H0020 cluster around BUCA’s average commercial benchmark of $61.20, with substantial variation by payer. UnitedHealth Group shows the highest central tendency with a median of $248.80 and a mean of $259.40, while Blue Cross Blue Shield centers much lower with a median of $15.90 and a mean of $21.70. Cigna and Aetna have similar central tendencies in the low $20s mean but different medians: Cigna median $12.20 and Aetna median $19.00. BUCA’s median of $54.60 sits between these groups as an average commercial reference point.
Dispersion measured by the interquartile range (P75–P25) highlights concentration differences: Blue Cross Blue Shield’s IQR is $6.40 (from $12.50 to $31.90), indicating one of the tighter distributions, while UnitedHealth Group’s IQR is $24.90 (from $236.30 to $261.20), the widest among listed payers. Cigna’s IQR is $5.80 and Aetna’s is $0.20, with Aetna being the tightest; BUCA’s IQR is $10.90 (from $50.80 to $65.70), showing moderate dispersion around its $61.20 mean.